Novel p53 splice site mutations in three families with Li-Fraumeni syndrome

被引:24
|
作者
Verselis, SJ
Rheinwald, JG
Fraumeni, JF
Li, FP [1 ]
机构
[1] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA
[4] Harvard Univ, Brigham & Womens Hosp, Sch Med, Skin Dis Res Ctr, Boston, MA 02115 USA
[5] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
关键词
p53; germline mutation; Li-Fraumeni syndrome; alternate splicing;
D O I
10.1038/sj.onc.1203758
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Germline mutations in the p53 tumor suppressor gene predispose to a variety of cancers in families with Li-Fraumeni syndrome. Most germline p53 mutations observed to date cause amino acid substitutions in the protein's central sequence-specific DNA binding domain. Outside this conserved core region, however, we found novel alterations in sequences that regulate precursor mRNA splicing in three Li-Fraumeni syndrome families. Two splice site mutations affected the consensus sequence at the splice donor sites of introns 1 and 9, and produced unstable variant transcripts in normal cells. A third mutation at the splice acceptor site of intron 9 generated splicing at a cryptic acceptor site in intron 9, These splice site alterations emphasize the need to examine both noncoding and untranslated regions of the p53 gene for germline mutations in Li-Fraumeni syndrome families.
引用
收藏
页码:4230 / 4235
页数:6
相关论文
共 50 条
  • [21] Li-Fraumeni and Li-Fraumeni-Like Syndrome Mutations in p53 Are Associated With Exonic Methylation and Splicing Regulatory Elements
    Kouidou, Sofia
    Malousi, Andigoni
    Maglaveras, Nicos
    MOLECULAR CARCINOGENESIS, 2009, 48 (10) : 895 - 902
  • [22] A novel dysfunctional germline P53 mutation identified in a family with Li-Fraumeni syndrome
    Ji, Min
    Wang, Lin
    Shao, Yuguo
    Cao, Wei
    Xu, Ting
    Chen, Shujie
    Wang, Zhiwei
    He, Qi
    Yang, Kuo
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (01): : 165 - 169
  • [23] Joint effects of germline p53 mutations and sex on cancer risk in Li-Fraumeni syndrome
    Wu, CC
    Shete, S
    Amos, CI
    Strong, LC
    GENETIC EPIDEMIOLOGY, 2005, 29 (03) : 288 - 289
  • [24] Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations
    Gonzalez, Kelly D.
    Noltner, Katie A.
    Buzin, Carolyn H.
    Gu, Dongqing
    Wen-Fong, Cindy Y.
    Nguyen, Vu Q.
    Han, Jennifer H.
    Lowstuter, Katrina
    Longmate, Jeffrey
    Sommer, Steve S.
    Weitzel, Jeffrey N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) : 1250 - 1256
  • [25] TP53 MUTATIONS AND LI-FRAUMENI SYNDROME
    Hainaut, P.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 703 - 703
  • [26] The function of a heterozygous p53 mutation in a Li-Fraumeni syndrome patient
    Li, Yang
    Li, Ting
    Tang, Yuejia
    Zhan, Zhiyan
    Ding, Lixia
    Song, Lili
    Yu, Tingting
    Yang, Yi
    Ma, Jing
    Zhang, Yingwen
    Zhou, Ying
    Gu, Song
    Xu, Min
    Gao, Yijin
    Li, Yanxin
    PLOS ONE, 2020, 15 (06):
  • [27] HETEROGENEITY IN LI-FRAUMENI FAMILIES - P53 MUTATION ANALYSIS AND IMMUNOHISTOCHEMICAL STAINING
    MACGEOCH, C
    TUMER, G
    BOBROW, LG
    BARNES, DM
    BISHOP, DT
    SPURR, NK
    JOURNAL OF MEDICAL GENETICS, 1995, 32 (03) : 186 - 190
  • [28] Li-Fraumeni Syndrome and p53 in 2015: Celebrating their Silver Anniversary
    Malkin, David
    CLINICAL AND INVESTIGATIVE MEDICINE, 2016, 39 (01): : E37 - E42
  • [29] GERMLINE P53 MUTATION (LI-FRAUMENI SYNDROME) RESULTING IN THREE SEQUENTIAL MALIGNANCIES IN A CHILD
    Allen, A. M.
    Kelly, D. R.
    Watts, R. G.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (02) : 454 - 454
  • [30] Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations
    Liu, PK
    Kraus, E
    Wu, TA
    Strong, LC
    Tainsky, MA
    ONCOGENE, 1996, 12 (11) : 2267 - 2278